Showing results (71-80 of 113) with videos related to

Sort By:
Pageof 12
Medical Physics|December 11, 2013
Quantitative Monte Carlo-based holmium-166 SPECT reconstructionMattijs Elschot, Maarten L J Smits, Johannes F W Nijsen, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 18, 2024
Dose-effect relationships in neuroendocrine tumour liver metastases treated with [<sup>166</sup>Ho]-radioembolizationK Ramdhani, J Beijer-Verduin, S C Ebbers, et al.
Plos One|July 30, 2013
Clinical and laboratory toxicity after intra-arterial radioembolization with (90)y-microspheres for unresectable liver metastasesMaarten L J Smits, Andor F van den Hoven, Charlotte E N M Rosenbaum, et al.
Cancers|September 9, 2022
Expression of SARS-CoV-2-Related Surface Proteins in Non-Small-Cell Lung Cancer Patients and the Influence of Standard of Care TherapyChristophe Deben, Maxim Le Compte, Vasiliki Siozopoulou, et al.
Redox Biology|April 4, 2021
Auranofin reveals therapeutic anticancer potential by triggering distinct molecular cell death mechanisms and innate immunity in mutant p53 non-small cell lung cancerLaurie Freire Boullosa, Jinthe Van Loenhout, Tal Flieswasser, et al.
Cardiovascular and Interventional Radiology|November 28, 2024
Radiation Lobectomy in Adjunct to Double Vein Embolization to Reach Sufficient Future Liver Remnant in Patients with Colorectal Cancer Liver Metastases: A Case SeriesD Andel, K Ramdhani, A J A T Braat, et al.
Diagnostics (Basel, Switzerland)|December 22, 2023
Prophylactic Medication during Radioembolization in Metastatic Liver Disease: Is It Really Necessary? A Retrospective Cohort Study and Systematic Review of the LiteratureManon N G J A Braat, Sander C Ebbers, Ahmed A Alsultan, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 12, 2019
First Evidence for a Dose-Response Relationship in Patients Treated with <sup>166</sup>Ho Radioembolization: A Prospective StudyRemco Bastiaannet, Caren van Roekel, Maarten L J Smits, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 14, 2014
(⁹⁹m)Tc-MAA overestimates the absorbed dose to the lungs in radioembolization: a quantitative evaluation in patients treated with ¹⁶⁶Ho-microspheresMattijs Elschot, Johannes F W Nijsen, Marnix G E H Lam, et al.
The Lancet. Oncology|August 28, 2012
Holmium-166 radioembolisation in patients with unresectable, chemorefractory liver metastases (HEPAR trial): a phase 1, dose-escalation studyMaarten L J Smits, Johannes F W Nijsen, Maurice A A J van den Bosch, et al.
Pageof 12